Investor · Cambridge, MA

Jason Rhodes

Open Jason in the network graph →

Filings

5

SEC Form D

Connections

35

co-filers

Capital

$329.5M

across filings

Active

Dec 2014

to Aug 2020

Most-connected co-filers (35)

Mark Angelino · Cambridge, MA2 shared Gustav Christensen · Cambridge, MA2 shared Donald Nicholson · Toronto, Ontario, Canada2 shared Anthony Quinn · Cambridge, MA2 shared Catherine Stehman-Breen · BOSTON, MA2 shared Jean M. George · Boston, MA1 shared Ed Hurwitz · Cambridge, MA1 shared David T. Lubner · Gaithersburg, MD1 shared David Grayzel · Waltham, MA1 shared Romesh Subramanian, Ph.D · Waltham, MA1 shared Oxana Beskrovnaya, Ph.D · Waltham, MA1 shared Catherine Stehman-Breen, M.D · Waltham, MA1 shared Jonathan Mcneill, M.D · Waltham, MA1 shared Dirk Kersten · Waltham, MA1 shared Edward Hurwitz · Waltham, MA1 shared Lawrence Klein, Ph.D · Waltham, MA1 shared Thomas Graney · Cambridge, MA1 shared Charlie Rowland · Cambridge, MA1 shared Jeff Jonas · Cambridge, MA1 shared Geoffrey Mcdonough · Cambridge, MA1 shared Glenn Goddard · Cambridge, MA1 shared Geoff Mcdonoughy · Cambridge, MA1 shared James Mclaughlin · New York, NY1 shared Peter Barrett · Cambridge, MA1 shared

Recent filings (5)

Dyne Therapeutics, Inc.Aug 2020 · 21 co-filers$115.7M Dyne Therapeutics, Inc.Aug 2020 · 21 co-filers$115.7M Generation Bio Co.Jan 2020 · 19 co-filers$111.5M Generation Bio Co.Jan 2020 · 19 co-filers$111.5M Generation Bio Co.Mar 2018 · 15 co-filers$100.4M Generation Bio Co.Mar 2018 · 15 co-filers$100.4M Gemini Therapeutics, Inc.May 2016 · 7 co-filers$2.0M Gemini Therapeutics, Inc.May 2016 · 7 co-filers$2.0M Atlas Venture Fund X, L.P.Dec 2014 · 13 co-filers$250.0M Atlas Venture Fund X, L.P.Dec 2014 · 13 co-filers$250.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jason in the interactive graph →